BALAXI PHARMA LTD·MISCELLANEOUS 53.39·Pharmaceuticals & Biotechnology Companies

2026-08-21 NSE Web 10%

Price

22.4

+0.44%
O:22.4
H:23
L:22.24
C:22.4

52W Range

15.249.65
+47%/-55%

Market Cap

₹123.66 Cr

Traded: ₹0.11 Cr (0.09%) 0.0x

Free Float: ₹31.51 Cr (0.36% of FF traded)

Volume · 60D trend

50.71 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-6% 3M:-5% 6M:-15% 12M:-25%

Valuation

P/E49.8
P/B0.5
P/S0.4
EV/EBIT137405338.1

Business Strength

ROE0.6%
ROCE3.1%
OPM3.3%
NPM0.4%

Growth (3Y CAGR)

EPS-94.3%
Sales-7.0%
Profit-69.0%
3Y Return-36.0%

Balance Sheet

Debt/Equity0.2
Debt55.74 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-400.0%
FCF-25.3 Cr
FCF 3Y Avg-78.2 Cr
Cash/MCap20.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle335 days
Tradeable Free Float25.5%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 0.08 L
0.00% FF
60d high
₹ 0.70 L
60d low
₹ 0
60d mean
₹ 0.45 L
vs mean
▼ 82.04%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
+8.0%
-4.0%
--
--
Decelerating
Return
+19.0%
-27.0%
-36.0%
-49.0%
--
Decelerating
Profit
--
-48.0%
-69.0%
--
-87.0%
Decelerating
Sales
--
+3.0%
-7.0%
--
-6.0%
Stable

Quarterly Results

Jun 2026

5 Aug
Rev
81 Cr
+14% YoY+14% QoQ
OPM5.8%
NPM1.6%
PAT
+348% YoY1 Cr
EPS
+380% YoY0.2

Mar 2026

29 May
Rev
71 Cr
-7% YoY-3% QoQ
OPM0.2%
NPM0.9%
PAT
-93% YoY1 Cr
EPS
-93% YoY0.1

Dec 2025

28 Jan
Rev
73 Cr
-1% YoY+29% QoQ
OPM4.3%
NPM0.4%
PAT
-94% YoY0 Cr
EPS
-94% YoY0.1

Sep 2025

PDF
Rev
56 Cr
-27% YoY-21% QoQ
OPM2.1%
NPM0.4%
PAT
-95% YoY0 Cr
EPS
-95% YoY0.0

Jun 2025

PDF
Rev
71 Cr
+8% YoY-7% QoQ
OPM5.9%
NPM0.4%
PAT
-96% YoY0 Cr
EPS
-96% YoY0.1

Mar 2025

PDF
Rev
76 Cr
+27% YoY+4% QoQ
OPM16.4%
NPM11.3%
PAT
-13% YoY9 Cr
EPS
-22% YoY1.6

Dec 2024

PDF
Rev
73 Cr
+21% YoY-5% QoQ
OPM5.4%
NPM7.3%
PAT
-55% YoY5 Cr
EPS
-63% YoY1.0

Sep 2024

PDF
Rev
77 Cr
+41% YoY+18% QoQ
OPM13.7%
NPM5.9%
PAT
-50% YoY5 Cr
EPS
-71% YoY0.8

Jun 2024

PDF
Rev
66 Cr
-1% YoY+10% QoQ
OPM15.4%
NPM9.9%
PAT
+91% YoY6 Cr
EPS
+115% YoY1.2

Mar 2024

PDF
Rev
60 Cr
-26% YoY-2% QoQ
OPM22.5%
NPM18.3%
PAT
+22% YoY11 Cr
EPS
+26% YoY2.0

Dec 2023

PDF
Rev
61 Cr
-30% YoY+11% QoQ
OPM22.4%
NPM22.4%
PAT
+46% YoY14 Cr
EPS
+62% YoY2.6

Sep 2023

PDF
Rev
55 Cr
---17% QoQ
OPM19.7%
NPM26.4%
PAT
-40% YoY14 Cr
EPS
--2.8

Jun 2023

PDF
Rev
66 Cr
---18% QoQ
OPM13.4%
NPM-62.7%
PAT
-76% YoY-41 Cr
EPS
---8.1

Mar 2023

PDF
Rev
81 Cr
---7% QoQ
OPM15.8%
NPM10.0%
PAT
-36% YoY8 Cr
EPS
--1.6

Dec 2022

Rev
87 Cr
----
OPM17.7%
NPM9.5%
PAT
-32% YoY8 Cr
EPS
--1.6

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.23
Interest Coverage-12.0x
Promoter Pledge0.0%
Borrowings58 Cr

Efficiency

Receivable Days184 days
Inventory Days202 days
Payable Days51 days
Cash Conversion cycle335 days

Cash Position

Operating Cash Flow-4 Cr
Investing Cash Flow-21 Cr
Financing Cash Flow0 Cr
Free Cash Flow-25 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023PDF ↗
Dec 2022
Sales817173567176737766606155668187
Expenses767169556764696756464744576871
Operating Profit50314134111013141191315
OPM %5.8%0.2%4.3%2.1%5.9%16.4%5.4%13.7%15.4%22.5%22.4%19.7%13.4%15.8%17.7%
Other Income-1302-2-24-4-2-126-48-0-5
Interest111111100100000
Depreciation111000000101010
Profit Before Tax2121110667111416-391111
Tax %38.3%56.4%80.8%84.1%67.0%10.6%11.7%17.4%12.1%4.9%4.8%7.9%4.9%26.8%21.9%
Net Profit110009556111414-4188
Exceptional Items--00000000126-4700
EPS (Rs)0.20.10.10.00.11.61.00.81.22.02.62.8-8.11.61.6
Sales Growth (YoY)14.1%-7.3%-1.0%-27.4%7.8%27.5%20.6%41.4%-0.5%-25.8%-29.8%--------
Sales Growth (QoQ)14.1%-2.5%29.1%-20.6%-7.3%4.1%-5.3%17.9%9.7%-1.6%11.1%-17.0%-18.2%-6.8%--
OP Growth (YoY)12.0%-99.0%-22.6%-89.0%-58.8%-6.8%-70.8%-1.6%14.1%5.6%-10.7%--------
OP Growth (QoQ)3783.3%-96.1%166.4%-72.1%-66.9%214.5%-62.3%5.0%-25.1%-1.3%26.9%21.7%-30.7%-16.6%--
Profit Growth (YoY)348.0%-93.0%-94.0%-95.0%-96.0%-13.0%-55.0%-50.0%91.0%22.0%46.0%-40.0%-76.0%-36.0%-32.0%
EPS Growth (YoY)380.0%-93.0%-93.8%-95.2%-95.7%-21.9%-63.4%-70.6%114.5%26.4%61.6%--------
EPS Growth (QoQ)118.2%83.3%50.0%-20.0%-96.8%61.9%16.9%-29.1%-41.8%-24.1%-6.0%134.9%-607.5%-3.0%--
OP Margin5.8%0.2%4.3%2.1%5.9%16.4%5.4%13.7%15.4%22.5%22.4%19.7%13.4%15.8%17.7%
Net Margin1.6%0.9%0.4%0.4%0.4%11.3%7.3%5.9%9.9%18.3%22.4%26.4%-62.7%10.0%9.5%
Material Cost %--57.0%58.0%52.0%56.0%52.0%60.0%57.0%58.0%48.0%50.0%53.0%61.0%63.0%61.0%
Employee Cost %--15.0%14.0%16.0%12.0%12.0%13.0%11.0%12.0%12.0%13.0%12.0%10.0%9.0%9.0%
P/S0.440.480.52------------------------
P/E49.7813.9715.24------------------------
P/B0.500.530.61------------------------

Shareholding Pattern

Shareholders:14.7K (+202.2%)
Current MixJun 2026

Annual Reports

11

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

Credit Ratings

4
crisilRating update
13 Nov 2025Report
crisilRating update
05 Nov 2024Report
crisilRating update
14 Aug 2023Report
crisilRating update
07 Sept 2022Report

Concalls

28

Jan 2026

31 Jan 2026

Nov 2025

30 Nov 2025

Aug 2025

31 Aug 2025

Jun 2025

30 Jun 2025

Feb 2025

28 Feb 2025

Nov 2024

30 Nov 2024

Aug 2024

31 Aug 2024

May 2024

31 May 2024

Feb 2024

29 Feb 2024

Nov 2023

30 Nov 2023

Aug 2023

31 Aug 2023

May 2023

31 May 2023

Feb 2023

28 Feb 2023

Jan 2023

31 Jan 2023

Nov 2022

30 Nov 2022

Nov 2022

30 Nov 2022

Oct 2022

31 Oct 2022

Aug 2022

31 Aug 2022

Aug 2022

31 Aug 2022

Aug 2022

31 Aug 2022

Jun 2022

30 Jun 2022

Jun 2022

30 Jun 2022

Feb 2022

28 Feb 2022

Nov 2021

30 Nov 2021

Jul 2021

31 Jul 2021

May 2021

31 May 2021

Feb 2021

28 Feb 2021

Oct 2020

31 Oct 2020